We found that RRM2 protein levels were reduced and that its cell distribution was altered towards an increasing nuclear localization, both in C9 ALS/FTD patient samples and upon HNRNPK depletion in HeLa cells. This evidence concerns the gene RRM2 and frontotemporal dementia.